Be Biopharma

Be Bio develops engineered B cell therapies that secrete therapeutic proteins to treat cancer, autoimmune, infectious, and enzyme diseases.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2020
Be Bio Portco Hover Image